AMGN – amgen inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day AMGN SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
11/4/2025
04:01 pm
amgn
amgen inc.
BEAT
7.8%
8/5/2025
04:01 pm
amgn
amgen inc.
BEAT
-5.1%
5/1/2025
04:01 pm
amgn
amgen inc.
BEAT
-0.9%
2/4/2025
04:01 pm
amgn
amgen inc.
BEAT
6.5%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/23 Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts 8.8%
8/8 Form 4 AMGEN INC For: Aug 07 Filed by: SUGAR RONALD D 6.2%
7/30 Amgen Reports Second Quarter 2019 Financial Results 6.1%
4/2 Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19 6.0%
8/26 UPDATE 2-Amgen to buy Celgene's psoriasis drug Otezla for $13.4 bln in cash [Reuters (UK)] 5.9%
4/7 Biotech Giant Amgen Entered The Coronavirus Arena — But Is It A Buy? [Investor's Business Daily] 5.9%
3/28 Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol 5.2%
8/12 Amgen, Inc. (NASDAQ: AMGN) had its "positive" rating re-affirmed by analysts at Wells Fargo & Co. They now have a $202.00 price target on the stock, up previously from $197.00. 5.0%
3/13 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at Cfra from a "hold" rating to a "buy" rating. 4.1%
3/26 Amgen, Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $250.00 to $240.00. They now have an "outperform" rating on the stock. 3.1%
Top News Decliners
3/14 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -6.8%
3/7 Hedge Funds Have Never Been This Bullish On NVIDIA Corporation (NVDA) [Yahoo! Finance News] -5.8%
2/27 Amgen, Inc. (NASDAQ: AMGN) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -5.1%
3/24 Form 4 AMGEN INC For: Mar 20 Filed by: REESE DAVID M -4.6%
4/30 Form 8-K AMGEN INC For: Apr 30 -4.6%
1/30 Q4/2019 12/31/2019 EPS 3.640 ZacksConsensus 3.470 ActVsEst 0.170 - Beat -4.5%
2/25 Amgen Stock Is Forming A Flat Base — Is It Time To Bet On AMGN Stock? [Investor's Business Daily] -3.8%
8/2 Form 4 AMGEN INC For: Aug 01 Filed by: Santos Esteban -3.1%
3/10 Form 4 AMGEN INC For: Mar 09 Filed by: REESE DAVID M -2.8%
3/31 Form 8-K AMGEN INC For: Mar 31 -2.8%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
AMGN – amgen inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
AMGN
SPY
QQQ
SPX
AMGN – amgen inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
AMGN SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
12/3
05:15 pm
amgn
Low
Amgen Inc. (AMGN) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/3
08:05 am
amgn
Low
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
12/2
03:00 am
amgn
Low
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Globe and Mail, The (Toronto, Canada)]
12/2
02:13 am
amgn
Low
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Yahoo! Finance]
11/29
11:43 pm
amgn
Low
Is Amgen's Recent Rally Justified After Strong Clinical Trial Results? [Yahoo! Finance]
11/29
03:35 am
amgn
Low
Amgen (NASDAQ:AMGN) was upgraded by analysts at Wall Street Zen from
11/25
07:37 pm
amgn
Low
IMDELLTRA's FDA Approval and Guideline Upgrade Could Be a Game Changer for Amgen (AMGN) [Yahoo! Finance]
11/25
08:05 am
amgn
Low
Amgen (NASDAQ:AMGN) was given a new $400.00 price target on by analysts at Wells Fargo & Company.
11/25
07:19 am
amgn
Low
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
11/4/2025
04:01 pm
amgn
7.8%
BEAT
8/5/2025
04:01 pm
amgn
-5.1%
BEAT
5/1/2025
04:01 pm
amgn
-0.9%
BEAT
2/4/2025
04:01 pm
amgn
6.5%
BEAT
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
12/3
08:49 am
Maintains
Outperform
Outperform
BMO Capital
Low
2.1%
12/3
08:49 am
Maintains
Outperform
Outperform
BMO Capital
Low
2.1%
12/3
08:05 am
Reiterates
Outperform
Outperform
BMO Capital Markets
Low
2.3%
11/14
07:50 am
Upgrades
Strong-Buy
Scotiabank
Low
-0.6%
11/14
07:50 am
Upgrades
Strong-Buy
Scotiabank
Low
-0.6%
11/13
09:19 am
Initiates
Outperform
Scotiabank
Low
0.4%
11/13
09:19 am
Initiates
Outperform
Scotiabank
Low
0.4%
11/12
04:17 pm
Initiates
OUTPERFORM
SCOTIABANK
Low
0.5%
11/12
04:17 pm
Initiates
OUTPERFORM
SCOTIABANK
Low
0.5%
11/21
08:35 pm
amgn
Low
Form 4 AMGEN INC For: Nov 20 Filed by: Grygiel Nancy A.
11/20
04:46 pm
amgn
Low
Form 144 AMGEN INC Filed by: Grygiel Nancy A.
11/13
07:29 pm
amgn
Low
Form 4 AMGEN INC For: Nov 12 Filed by: Khosla Rachna
11/13
07:28 pm
amgn
Low
Form 4 AMGEN INC For: Nov 12 Filed by: Gordon Murdo
11/12
07:42 pm
amgn
Low
Form 4 AMGEN INC For: Nov 11 Filed by: REESE DAVID M
11/12
07:33 pm
amgn
Low
Form 4 AMGEN INC For: Nov 07 Filed by: ISHRAK OMAR
11/12
07:32 pm
amgn
Low
Form 4 AMGEN INC For: Nov 07 Filed by: HOLLEY CHARLES M
11/12
07:31 pm
amgn
Low
Form 4 AMGEN INC For: Nov 07 Filed by: Drake Michael V
11/12
03:02 pm
amgn
Low
Form 144 AMGEN INC Filed by: Gordon Murdo
Show more
Top News Gainers
3/23 Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts 8.8%
8/8 Form 4 AMGEN INC For: Aug 07 Filed by: SUGAR RONALD D 6.2%
7/30 Amgen Reports Second Quarter 2019 Financial Results 6.1%
4/2 Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19 6.0%
8/26 UPDATE 2-Amgen to buy Celgene's psoriasis drug Otezla for $13.4 bln in cash [Reuters (UK)] 5.9%
4/7 Biotech Giant Amgen Entered The Coronavirus Arena — But Is It A Buy? [Investor's Business Daily] 5.9%
3/28 Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol 5.2%
8/12 Amgen, Inc. (NASDAQ: AMGN) had its "positive" rating re-affirmed by analysts at Wells Fargo & Co. They now have a $202.00 price target on the stock, up previously from $197.00. 5.0%
3/13 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at Cfra from a "hold" rating to a "buy" rating. 4.1%
3/26 Amgen, Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $250.00 to $240.00. They now have an "outperform" rating on the stock. 3.1%
Top News Decliners
3/14 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -6.8%
3/7 Hedge Funds Have Never Been This Bullish On NVIDIA Corporation (NVDA) [Yahoo! Finance News] -5.8%
2/27 Amgen, Inc. (NASDAQ: AMGN) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -5.1%
3/24 Form 4 AMGEN INC For: Mar 20 Filed by: REESE DAVID M -4.6%
4/30 Form 8-K AMGEN INC For: Apr 30 -4.6%
1/30 Q4/2019 12/31/2019 EPS 3.640 ZacksConsensus 3.470 ActVsEst 0.170 - Beat -4.5%
2/25 Amgen Stock Is Forming A Flat Base — Is It Time To Bet On AMGN Stock? [Investor's Business Daily] -3.8%
8/2 Form 4 AMGEN INC For: Aug 01 Filed by: Santos Esteban -3.1%
3/10 Form 4 AMGEN INC For: Mar 09 Filed by: REESE DAVID M -2.8%
3/31 Form 8-K AMGEN INC For: Mar 31 -2.8%